We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
For manufacturers reporting adverse incidents with joint replacement implants under the vigilance system.
Outcomes from the first meeting with the regulators of medicine who had met globally to discuss dementia.
Report on how community pharmacies can improve the prevention, early detection and management of blood pressure.
Outlines the level of payment due from members of the Pharmaceutical Price Regulation Scheme (PPRS) in 2018.
For manufacturers reporting adverse incidents with intraocular lenses under the vigilance system.
A letter providing guidance on the post-transition conversion process was sent by email on 23 October 2020 to the Community MA holders.
Submission of notifications for Northern Ireland under article 20 of directive 2014/40/EU.
Information for healthcare professionals, patients, and the public.
Guidance and change control form to request a change to an Advisory Committee on Borderline Substances (ACBS) application form and/or guidance.
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
Guidance for healthcare establishments that manufacture medical devices in-house.
Guidance on moving medicines by air
We are allowing alternative courses of actions for manufacturing or laboratory equipment during the outbreak.
For manufacturers reporting adverse incidents with biological/mechanical surgical heart valves under the vigilance system.
How equipment for temperature screening is regulated, the limitations of temperature screening for detecting COVID-19 and advice on buying and using these products.
UK businesses can apply for a share of up to £8 million from the Industrial Strategy Challenge Fund for capital projects to improve medicines manufacturing.
Data submission requirements for acute, community and private microbiology services submitting data on all LA/NHS chlamydia tests done in England.
How to use PharmaQC to access pharmaceutical suppliers, Quality Control (QC) pharmacists and Commercial Medicines Unit (CMU) buyers.
Sets out opportunities for commissioners and providers to realise community pharmacy’s role in protecting and improving the nation's health.
General advice on vigilance - electronic cigarettes devices and refill containers.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).